Dubbewar AP, Pathak B, Biswas M, Malhotra G. Combined use of CA 125 and Inhibin as tumor marker for detection of ovarian cancer in comparison to CA 125 or Inhibin alone. Int J Reprod Contracept Obstet Gynecol [Internet]. 2017 Nov. 23 [cited 2025 Oct. 2];6(12):5313-6. Available from: https://www.ijrcog.org/index.php/ijrcog/article/view/4024